Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to...
Read More
Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the answer to secure the supply chain? Counterfeit medicines are a multi-billion...
Read More
When a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to differentiate their early stage assets, they approached Innoplexus. That decision...
Read More
Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his 2005 book chapter Bridging the Quality Chasm: “Between $.30 and $.40...
Read More
The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one...
Read More
In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world. As the Nobel-prize-winning economist Daniel...
Read More
When medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel therapeutics to market. As Ginny Rometti, the current CEO of IBM...
Read More
The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue? We live in an...
Read More
Making more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can be repurposed and used for faster treatment of serious terminal...
Read More
Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s no secret that drug prices are a controversial issue. Just...
Read More
